- Investing Ideas
- Swedish Pharmaceuticals & Biotech Nano Cap Stocks
Swedish Pharmaceuticals & Biotech Nano Cap Stocks
Results
8
Stocks with a market cap under US$50M.
8 companies
Cantargia
Market Cap: SEK 456.9m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.84
7D
-7.6%
1Y
-31.2%
Sprint Bioscience
Market Cap: SEK 386.2m
A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.
SPRINT
SEK 3.66
7D
-5.2%
1Y
601.1%
Elicera Therapeutics
Market Cap: SEK 178.2m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.67
7D
-3.4%
1Y
-52.6%
Ascelia Pharma
Market Cap: SEK 65.4m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.49
7D
-26.2%
1Y
-89.1%
Subgen AI
Market Cap: SEK 65.2m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.064
7D
2.6%
1Y
n/a
ODI Pharma
Market Cap: SEK 42.2m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 2.30
7D
0%
1Y
15.0%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs cisplatin for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%